Clinical trials

Filters
Clear filters
1,718 trials
TrialSponsorPhaseStatusPrimary completion
A Recovery and Lifespan Study Using INTERCEPT Red Blood Cells Prepared Using the INTERCEPT Blood System for RBCs With AS-1NCT07015437Cerus CorporationPhase 2Recruiting2026-12-15Estimated
A Study Comparing KB803 and Matched Placebo in Patients With Dystrophic Epidermolysis BullosaNCT07016750KRYSPhase 3Recruiting2026-12Estimated
A Clinical Trial of Elsunersen in Pediatric SCN2A-DEE to Assess Efficacy and SafetyNCT07019922Praxis Precision MedicinesPhase 3Recruiting2026-12Estimated
A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid TumorsNCT07020221VSTMPhase 1, Phase 2Recruiting2028-12Estimated
An Open Label Clinical Study to Evaluate Tanruprubart (Also Commonly Known as ANX005) in Participants With Guillain-Barré Syndrome (FORWARD Study)NCT07020819ANNXPhase 3Recruiting2027-05-31Estimated
Monthly Dosing of Atacicept in IgANNCT07020923VERAPhase 2Active not recruiting2026-09-22Actual
A Study to Evaluate ARV-806 in Adults With Advanced Cancer That Has the KRAS G12D MutationNCT07023731ARVNPhase 1, Phase 2Completed2026-10-30Actual
DT-168 in Keratoplasty Patients With Fuchs Endothelial Corneal DystrophyNCT07024693DSGNPhase 2Recruiting2027-12Estimated
Study to Evaluate Efficacy and Dose Response of Imapextide (STEADI)NCT07029412MBX BiosciencesPhase 2Completed2026-04-18Actual
Phase 2, Efficacy and Safety Study of ACP-204 in Lewy Body Dementia PsychosisNCT07029581ACADPhase 2Recruiting2028-02Estimated
C-Forward: Efficacy and Safety of BEM/RZR vs SOF/VEL in Subjects With Chronic HCVNCT07037277AVIRPhase 3Active not recruiting2026-12Estimated
A Phase 3 Study of Zodasiran in Adolescent and Adult Subjects With Homozygous Familial Hypercholesterolemia (YOSEMITE)NCT07037771Arrowhead PharmaceuticalsPhase 3Active not recruiting2027-08-20Estimated
A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Inpatient Adults With SchizophreniaNCT07038876MapLight TherapeuticsPhase 2Completed2026-06-04Actual
FMXIN002 in Patients at Risk of AnaphylaxisNCT07045701Nasus PharmaPhase 2, Phase 3Enrolling by invitation2026-06-12Estimated
Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Bipolar I DisorderNCT07046494RAPPPhase 2Completed2026-08-05Actual
A Study to Evaluate How Apitegromab Works in Subjects Who Are Less Than 2 Years Old and Have Spinal Muscular AtrophyNCT07047144Scholar Rock, Inc.Phase 2Recruiting2028-11Estimated
Single Intravitreal (IVT) Injection of 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular DegenerationNCT070647594D Molecular TherapeuticsPhase 3Recruiting2027-11Estimated
A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)NCT07065240Seaport TherapeuticsPhase 2Recruiting2027-03Estimated
Safety, Tolerability and Efficacy of Trichostatin A in Patients With Mild to Severe OnychomycosisNCT07065773Vanda PharmaceuticalsPhase 2Active not recruiting2026-09Estimated
A Study of Orelabrutinib in Patients With Primary Progressive Multiple SclerosisNCT07067463Zenas BioPharma (USA), LLCPhase 3Recruiting2030-06Estimated
Phase 2 Trial to Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral ImplantNCT07075718Glaukos CorporationPhase 2Recruiting2028-03Estimated
A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder (X-NOVA3)NCT07076407XENEPhase 3Active not recruiting2027-05Estimated
Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast CancerNCT07085767—Phase 3Recruiting2028-12Estimated
Evaluation of Efficacy and Safety of Iloperidone for the Treatment of Participants With Uncontrolled HypertensionNCT07090161Vanda PharmaceuticalsPhase 2Recruiting2026-10Estimated
ORKA-001 Versus Placebo in Patients With Moderate-to-Severe Plaque PsoriasisNCT07090330ORKAPhase 2Active not recruiting2026-03-25Actual
Phase 3, Open Label Extension Study of ACP-204 in Lewy Body Dementia PsychosisNCT07095465ACADPhase 3Recruiting2029-02Estimated
A Phase 2 Study of Budoprutug in Subjects With Primary Membranous NephropathyNCT07096843CLYMPhase 2Recruiting2027-10Estimated
A Phase 2 Neoadjuvant Study of Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive Breast CancerNCT07102381Jazz PharmaceuticalsPhase 2Recruiting2027-12-29Estimated
An Efficacy and Safety Study of LTG-001 Following AbdominoplastyNCT07102459Latigo BiotherapeuticsPhase 2Completed2026-01-07Actual
VK2735 for Weight Management Type 2 Diabetes Phase 3 (VANQUISH 2)NCT07104383VKTXPhase 3Active not recruiting2027-07-01Estimated

Primary completion marks the end of data collection for the main study measures, not a results publication date.